View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. Uncategorised
April 28, 2020updated 29 Apr 2020 9:58am

More than half of age-related macular degeneration cases go undiagnosed in major pharmaceutical markets

By Adam Williams

Age-related macular degeneration (AMD) is a progressive eye disease that affects the retina, the area of the eye responsible for central vision and sharpness. AMD is the most common cause of irreversible vision loss among the elderly, specifically those ages 50 years and older.

In the nine major pharmaceutical markets (9MM: US, France, Germany, Italy, Spain, UK, Japan, Australia, and China), GlobalData epidemiologists found that less than half of AMD cases were diagnosed in 2019, with Japan and China experiencing the most undiagnosed cases due to the large number of AMD cases in these markets.

Related Companies

Topics in this article:
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy